Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition
Open Access
- 19 November 2010
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 163 (2), 250-259
- https://doi.org/10.1111/j.1365-2249.2010.04286.x
Abstract
Commensal bacteria have been shown to modulate the host mucosal immune system. Here, we report that oral treatment of BALB/c mice with components from the commensal, Parabacteroides distasonis, significantly reduces the severity of intestinal inflammation in murine models of acute and chronic colitis induced by dextran sulphate sodium (DSS). The membranous fraction of P. distasonis (mPd) prevented DSS-induced increases in several proinflammatory cytokines, increased mPd-specific serum antibodies and stabilized the intestinal microbial ecology. The anti-colitic effect of oral mPd was not observed in severe combined immunodeficient mice and probably involved induction of specific antibody responses and stabilization of the intestinal microbiota. Our results suggest that specific bacterial components derived from the commensal bacterium, P. distasonis, may be useful in the development of new therapeutic strategies for chronic inflammatory disorders such as inflammatory bowel disease.Keywords
This publication has 45 references indexed in Scilit:
- Enteric defensins are essential regulators of intestinal microbial ecologyNature Immunology, 2009
- Nod2 is required for the regulation of commensal microbiota in the intestineProceedings of the National Academy of Sciences of the United States of America, 2009
- Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free miceBMC Immunology, 2008
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patientsProceedings of the National Academy of Sciences of the United States of America, 2008
- A microbial symbiosis factor prevents intestinal inflammatory diseaseNature, 2008
- Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's DiseaseJournal of Clinical Microbiology, 2006
- Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouseImmunology, 2006
- Escherichia coli Strain Nissle 1917 Ameliorates Experimental Colitis via Toll-Like Receptor 2- and Toll-Like Receptor 4-Dependent PathwaysInfection and Immunity, 2006
- InfliximabDrugs, 2005
- Host–bacterial interactions in inflammatory bowel diseaseClinical Science, 2004